In a little over 5 months time, the World Vaccine Congress will once again be heading to Washington DC. In preparation for the event, we will producing content that we feel is relevant to the industry. To begin with, we asked the question: Which countries will become the next biggest markets for CROs – Who’s after China and India?
Over the past 10 years, CROs have raised their levels of services and become more sophisticated operations. They're becoming the place where expertise resides. In fact, the period from 2010-2012 marked the first time employment at CROs exceeded those at major pharmas on the clinical side, according to a study conducted by Tufts CSDD. Some 46,550 worked in clinical at CROs and 41,275 worked in clinical at major pharmas.
As the outsourcing market continues to grow, so has the number of attractive locations for clinical trials. Smaller countries have joined the usual suspects--such as China and India on the CRO map.
With some insight from the Association of Clinical Research Organizations (ACRO) and Pharma companies, such as Pfizer, Novartis and Sanofi, we asked which countries were the next promising, upwardly mobile countries in offering outsourcing services for the vaccines industry.
Download the eBook to take a look at the next biggest markets for CROs – Who’s after China and India?